Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,664.00    -4.00 (-0.24%)
Bid:
1,662.00
Ask:
1,668.00
Spread: 6.00 (0.361%)
Market Cap: £490.08m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Half Year Trading Update

9 Apr 2021 07:00

RNS Number : 8995U
Avon Rubber PLC
09 April 2021
 

9 April 2021

Avon Rubber p.l.c.

Half Year Trading Update

 

Avon Rubber p.l.c. ("Avon Rubber" or "the Group") today provides the following trading update for its current financial year ending 30 September 2021.

 

Summary

Further to the AGM update on 29 January 2021, trading in the second quarter continued to be strong with ongoing positive momentum and continued strong order intake across our portfolio of life critical personal protection systems for the world's militaries and first responders. The Group expects to report revenue of $122 million for the first half (H1 2020: $87 million), including a first-time contribution from Team Wendy of $20m during the first five months of ownership.

 

As a result and taking into account the current order book of $155m and expected order intake in the second half, the Board remains confident of achieving its expectations for the current financial year. 

 

Military

Within our Military business, revenues increased by 16% year-on-year driven by strong growth in respiratory protection. Orders received in the first half were up 30% , including $38 million of initial orders under the NATO Support & Procurement Agency contract, $17 million under the U.S. Department of Defense M69 aircrew mask system contract and the recently announced $19 million order under the existing U.S. Army Integrated Head Protection System ("IHPS") contract.

 

We expect the U.S. Army to commence the tender process for a multi-year, multi-source full rate production contract for the next generation IHPS during the second half of our current financial year. We believe our product continues to represent the optimal solution for the customer and that the tender process will provide medium term visibility for the IHPS programme.

 

We are in the process of finalising revised designs for the U.S. Defense Logistics Agency Enhanced Small Arms Protective Inserts ("DLA ESAPI") contract with the customer and remain on schedule to complete first article testing during the second half of the year with first deliveries expected to commence in the first half of our 2022 financial year.

 

First Responder

Within our First Responder business, we have continued to see strong demand across our entire respiratory and ballistic protection range with revenues increasing by 19% year-on-year in the first half and orders received up 29% . We have also continued to see a strong pipeline of opportunities to further broaden our customer base across both our respiratory and ballistic product portfolios.

 

Team Wendy

Team Wendy has continued to perform well and in line with expectations in the first five months of ownership with continuing strong order intake.

 

Financial Update

The Group's financial position remains strong, with net debt before lease liabilities of $13 million at 31 March 2021, representing leverage of less than 0.2x consensus EBITDA for the current financial year.

 

The weighting of revenues to the second half of the year, together with increased inventory holdings to manage longer material lead times, has reduced cash conversion in the first half; however the Board expects full year cash conversion to be in line with its 90% plus guidance.

 

Notice of Results

The Group will release its results for the six months ended 31 March 2021 on 25 May 2021.

 

For further enquiries, please contact:

 

Avon Rubber p.l.c.

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

Ryan Mahoney, Deputy Chief Financial Officer

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

avonrubber@mhpc.com

Pete Lambie

Ailsa Prestige

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Note to editors: 

Avon Rubber is listed on the London Stock Exchange (LSE: AVON) and is a constituent of the FTSE 250 Index.

Avon Rubber is an innovative technology group, which designs and produces life critical personal protection systems to maximise the performance and capabilities of its customers, with leading positions in the respiratory and ballistic protection markets for the world's militaries and first responders.

For further information, please visit our website: www.avon-rubber.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAKLPELXFEFA
Date   Source Headline
14th Dec 201510:38 amRNSDirectorate Change
7th Dec 20155:04 pmRNSDirector/PDMR Shareholding
4th Dec 20155:42 pmRNSAnnual Financial Report
2nd Dec 201512:04 pmRNSDirector/PDMR Shareholding
30th Nov 20153:30 pmRNSDirectors' and PDMRs' Interest in Shares
30th Nov 201512:05 pmRNSHolding(s) in Company
30th Nov 20159:06 amRNSHolding(s) in Company
25th Nov 20155:42 pmRNSHolding(s) in Company
23rd Nov 20152:10 pmRNSHolding(s) in Company
20th Nov 201512:29 pmRNSDirector/PDMR Shareholding
19th Nov 20154:51 pmRNSDirector/PDMR Shareholding
17th Nov 20151:00 pmRNSFinal Results
5th Nov 20155:39 pmRNSDirectors'/PDMR Shareholdings
9th Oct 20157:00 amRNSAcquisition
7th Oct 20158:53 amRNSDirector/PDMR Shareholding
6th Oct 20157:00 amRNSPre close trading update
1st Oct 20157:00 amRNSDirectorate Change
8th Sep 20153:26 pmRNSDirector/PDMR Shareholding
2nd Sep 20157:00 amRNSTrading Update
7th Aug 20154:04 pmRNSHolding(s) in Company
6th Aug 20153:35 pmRNSDirector/PDMR Shareholding
6th Aug 20157:00 amRNSAcquisition
8th Jul 20155:34 pmRNSDirector/PDMR Shareholding
29th Jun 20154:27 pmRNSHolding(s) in Company
29th Jun 201511:20 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSAcquisition
8th Jun 20159:03 amRNSDirector/PDMR Shareholding
1st Jun 20155:01 pmRNSHolding(s) in Company
6th May 20157:02 amRNSDirector/PDMR Shareholding
29th Apr 20157:01 amRNSBoard Change
29th Apr 20157:00 amRNSHalf Yearly Report
8th Apr 20154:24 pmRNSDirector/PDMR Shareholding
26th Mar 201512:22 pmRNSDirector Declaration
5th Mar 20156:30 pmRNSDirector/PDMR Shareholding
25th Feb 201512:24 pmRNSDirectorate Change
17th Feb 20153:55 pmRNSHolding(s) in Company
5th Feb 20153:33 pmRNSDirector/PDMR Shareholding
29th Jan 20151:06 pmRNSResult of AGM and Retirement of Director
29th Jan 20157:00 amRNSAGM Statement
28th Jan 201512:11 pmRNSHolding(s) in Company
20th Jan 201511:50 amRNSDirector/PDMR Shareholding
9th Jan 20153:58 pmRNSDirector/PDMR Shareholding
9th Jan 201510:22 amRNSAnnual Financial Report
6th Jan 20159:42 amRNSDirector/PDMR Shareholding
5th Jan 201512:17 pmRNSDirector/PDMR Shareholding
8th Dec 20145:11 pmRNSDirector/PDMR Shareholding
2nd Dec 20142:31 pmRNSDirector/PDMR Shareholding
2nd Dec 20142:31 pmRNSDirector/PDMR Shareholding
1st Dec 20149:52 amRNSDirector/PDMR Shareholding
19th Nov 20147:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.